AET

Cannabinoid drug developer GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) is ending an eventful 2016 on a high note. Shares were surging higher by 6.6 percent on Monday following new drug data out over the weekend and a strong fiscal Q4 earnings report out Monday. Over the weekend, the company reported...